Bone Remodeling under Pathological Conditions

Frontiers of Oral Biology

Volumn 18, Issue , 2015, Pages 17-27

  Xiao, Wenmei ^a,c   Li, Shuai ^a,c   Pacios, Sandra ^c,d   Wang, Yu ^b,c   Graves, Dana T ^c  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID;

ADVERSE EFFECTS; ARTHRITIS; BIOMECHANICS; BONE DEVELOPMENT; BONE DISEASE; BONE REMODELING; HUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; WEIGHTLESSNESS;

ARTHRITIS; BIOMECHANICAL PHENOMENA; BONE DISEASES; BONE REMODELING; BONE RESORPTION; HUMANS; INFLAMMATION MEDIATORS; OSTEOGENESIS; OSTEOPOROSIS, POSTMENOPAUSAL; PERIODONTAL DISEASES; WEIGHTLESSNESS;

EID: 84949208000     PISSN: 14202433     EISSN: 16623770     Source Type: Book Series    
DOI: 10.1159/000351896     Document Type: Article

References (28)

1. Lecart MP, Reginster JY: Current options for the management of postmenopausal osteoporosis. Expert Opin Pharmacother 2011; 12: 2533-2552.
2. Pacifici R: Estrogen deficiency, T cells and bone loss. Cell Immunol 2008; 252: 68-80.
3. Chang J, Wang Z, Tang E, et al: Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 2009; 15: 682-689.
4. Lewiecki EM: New targets for intervention in the treatment of postmenopausal osteoporosis. Nat Rev Rheumatol 2011; 7: 631-638.
5. Karmakar S, Kay J, Gravallese EM: Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am 2010; 36: 385-404.
6. Maruotti N, Grano M, Colucci S, d'Onofrio F, Cantatore FP: Osteoclastogenesis and arthritis. Clin Exp Med 2011; 11: 137-145.
7. Walsh NC, Gravallese EM: Bone remodeling in rheumatic disease: A question of balance. Immunol Rev 2010; 233: 301-312.
8. Szekanecz Z, Koch AE, Tak PP: Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. Neth J Med 2011; 69: 356-366.
9. Graves DT, Li J, Cochran DL: Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res 2010; 90: 143-153.
10. Graves DT, Oates T, Garlet GP: Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011; 3: 5304.
11. Scott DA, Krauss J: Neutrophils in periodontal inflammation. Front Oral Biol 2012; 15: 56-83.
12. Xiao W, Wang Y, Pacios S, Li S, Graves DT: Cellular and molecular aspects of bone remodeling. Monogr Oral Sci 2012, in press.
13. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS: Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003; 38: 210-217.
14. Jin Q, Cirelli JA, Park CH, et al: RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007; 78: 1300-1308.
15. Giannobile WV: Host-response therapeutics for periodontal diseases. J Periodontol 2008; 79: 1592-1600.
16. Pacios S, Kang J, Galicia J, et al: Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012; 26: 1423-1430.
17. Behl Y, Siqueira M, Ortiz J, et al: Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 2008; 181: 8711-8718.
18. Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT: Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006; 55: 487-495.
19. Hasturk H, Kantarci A, Van Dyke TE: Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012; 15: 160-176.
20. Tamma R, Colaianni G, Camerino C, et al: Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption. FASEB J 2009; 23: 2549-2554.
21. Bloomfield SA: Disuse osteopenia. Curr Osteoporos Rep 2010; 8: 91-97.
22. Bergmann P, Body JJ, Boonen S, et al: Loading and skeletal development and maintenance. J Osteoporos 2010; 2011: 786752.
23. Huang Y, Dai ZQ, Ling SK, et al: Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells. J Biomed Sci 2009; 16: 87.
24. Hughes JM, Petit MA: Biological underpinnings of Frost's mechanostat thresholds: The important role of osteocytes. J Musculoskelet Neuronal Interact 2010; 10: 128-135.
25. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM: RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res 2005; 20: 1858-1866.
26. Nabavi N, Khandani A, Camirand A, et al: Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion. Bone 2011; 49: 965-974.
27. Sievänen H: Immobilization and bone structure in humans. Arch Biochem Biophys 2010; 503: 146-152.
28. Takayanagi H: Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 2009; 5: 667-676.